Oral Microbiota Dysbiosis in IBD
NCT06980818 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2025-05-20
Summary
This study aims to provide new insights into oral microbiota dysbiosis and IBD. Given the strong association between oral health, microbiome composition, and IBD, all participants will undergo an oral evaluation program conducted by dentists from the Faculty of Dentistry at Universidade Católica Portuguesa (UCP). This program will facilitate the characterization of oral health and its correlation with IBD status.
Conditions
- Inflammatory Bowel Disease (IBD)
- Dysbiosis
Interventions
- OTHER
-
No intervention
No intervention will take place.
Sponsors & Collaborators
-
ULS Viseu Dão Lafões
lead OTHER
Principal Investigators
-
Paula Ministro, MD · ULS Viseu Dão Lafões
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-11
- Primary Completion
- 2025-11-30
- Completion
- 2025-12-31
Countries
- Portugal
Study Locations
More Related Trials
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Oral Health-related Quality of Life (OHRQoL) in Patients With Inflammatory Bowel Disease (IBD)
NCT05096897 ·Status: COMPLETED
-
Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
NCT06516237 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506 ·Status: WITHDRAWN
-
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
NCT01852760 ·Status: COMPLETED
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
NCT06722456 ·Status: ENROLLING_BY_INVITATION
-
The Effect of Non-Surgical Periodontal Therapy on Inflammatory Bowel Disease
NCT06245278 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
NCT05456893 ·Status: RECRUITING
-
Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT00780507 ·Status: COMPLETED
-
Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis
NCT05680883 ·Status: UNKNOWN
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
CP101 for the Treatment of Ulcerative Colitis
NCT05852574 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Identifying Saliva Markers in Inflammatory Bowel Disease
NCT01590043 ·Status: UNKNOWN
-
A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis
NCT06918093 ·Status: NOT_YET_RECRUITING
-
Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases
NCT01990716 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
NCT00222378 ·Status: COMPLETED
-
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients
NCT01341808 ·Status: COMPLETED ·Phase: PHASE4
-
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
NCT01676324 ·Status: COMPLETED
-
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06939569 ·Status: RECRUITING
-
The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis
NCT03151850 ·Status: UNKNOWN
-
Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain
NCT03689257 ·Status: COMPLETED
-
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
NCT05014555 ·Status: UNKNOWN
-
Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital
NCT05183256 ·Status: COMPLETED
-
A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
NCT07083193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2